PSM submits comment on USPTO anti-counterfeiting initiative
On August 3, the Partnership for Safe Medicines submitted comment on the U.S. Patent and Trademark Office's Future Strategies in Anticounterfeiting and Antipiracy, an initiative to gather ideas about deterring counterfeiting and piracy that is affecting all areas of U.S. commerce.
The problem is substantial: Customs and Border Protection's (CBP's) Intellectual Property Rights Seizure Statistics showed a 152% increase between fiscal year 2020 and fiscal year 2021. Over the same period, the number of different kinds of medicines CBP agents seized rose 30 percent.
PSM's submission described current efforts to use trademark law to stop counterfeiters from making and selling fake and unreliable medicine that threatens the health of Americans. Read it here.